Future Cosmeceuticals of Dermatologic Importance

Published on 15/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1514 times

Chapter 32 Future Cosmeceuticals of Dermatologic Importance

GENISTEIN

Genistein is a soybean isoflavone that was first isolated from soy beans in 1931. It is a potent antioxidant with specific inhibitors of protein tyrosine, kinase, and phytoestrogens, increasing the thickness of the skin through an estrogenic effect. It has been found that it exhibits properties preventing the hemolysis of red blood cells by dialuric acid or H2O2 and inhibiting microsomal lipid peroxidation induced by Fe2+-ADP complex and NAPDH. It is the most potent inhibitor of P450-mediated activation of benzo[a]pyrene among all isoflavones.

Multiple studies over the past decade have given support to the belief that these natural ingredients have preventive and therapeutic effects on breast and prostate cancers, osteoporosis, cardiovascular diseases (in humans and animals), and postmenopausal syndrome. Genistein has significant effects in terms of inhibition of chemical carcinogenesis, UV-induced skin carcinogenesis and photo-damage in both humans and mice.

Although numerous in vitro studies have shown its potential in anticancer properties, evidence is lacking on its effect on skin carcinogenesis, but there is scientific support for its potential. Genistein has been found to have chemopreventive and strong anticancer activities. It has been shown to inhibit the activity of tyrosine protein kinase (TPK), topoisomerase II (Topo II), and ribosomal S6 kinase (RS6K) in cell culture. It has also been shown to inhibit growth of the ras oncogene and decrease PD6F-induced c-fos and c-jun expression in fibroblasts. Experiments were conducted to prove that genistein substantially blocks subacute and chronic UVB- and PUVA-induced cutaneous damage (Box 32.1; Figs 32.2 and 32.3).

GLOBAL REJUVENATION AGENTS

Vitis vinifera

Vitis vinifera is a grape seed extract rich in flavonoids and phytochemicals. This grape seed extract is used in facial creams throughout Europe and is known to be much more effective than vitamins E and C on keratinocytes after H2O2 exposure. The grape seed extract is used in treating diseases of the skin, such as psoriasis and eczema, by blocking the disruption of the chemical structure of enzymes used in collagen building. Bioflavonoids in the extract promote fast absorption into the skin. These oxidative properties are also used in treating various other ailments and diseases such as preventing heart disease by acting as an anticoagulative agent, minimizing fibromyalgia damage by protecting muscle cells, lessening allergy symptoms as it acts as a natural antihistamine, deterring cancer by neutralizing the cellular change of the genetic material within a cell that may result in tumor formulation, slowing the progression of macular degeneration, and regulating hepatic architecture.

In one study comparing a serum and a cream versus a serum, both of which contained the Vitis vinifera shoot extract (grape seed), 26 subjects used the serum twice a day for 28 days and 30 subjects used the serum and cream twice a day for the same time period. The treatment area was the face and neck. Improvement in firmness, radiant glow, softness, texture, fine lines and wrinkles were tracked. There was no significant difference in findings between the serum and cream and the serum group. Fifty-four percent of the serum-treated subjects noted an overall global improvement greater than 25% (using a quartile scale) while 60% of the serum and cream group noted equal improvement.

FURTHER READING

Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry. 1987;262:5592–5595.

Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology. 1998;91:6–11.

Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological activities in a liposomal system. Archives of Biochemistry and Biophysics. 1998;356:133–141.

Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause. 1997;42:89–94.

Cai Q, Wei H. Effects of dietary genistein on antioxidant enzyme activities in Sencar mice. Nutrition and Cancer. 1996;25:1–7.

Correa P. Epidemiological correlations between diet and cancer frequency. Cancer Research. 1981;41:3685–3690.

Cornacchione S, Neveu M, Talbourdet S, et al. In vivo skin antioxidant effect of a new combination based on a specific Vitis vinifera shoot extract and a biotechnological extract. Journal of Drugs in Dermatology. 2007;6:S8-S18.

Draelos Z. Botanical antioxidants. Cosmetic Dermatology. 2003;16:46–48.

Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proceedings of the National Academy of Sciences USA. 1993;90:2690–2694.

Gyorgy P, Murata K, Ikehata H. Antioxidants isolated from fermented soybeans (tempeh). Nature. 1964;203:870–872.

Kang S, Chung JH, Lee JH, et al. Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo. Journal of Investigative Dermatology. 2003;120:835–841.

Kapiotis S, Hermann M, Held I, et al. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arteriosclerosis, Thrombosis and Vascular Biology. 1997;17:2868–2874.

Kiguchi K, Constantinou A, Huberman E. Genistein induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Communications. 1990;2:271–278.

Lambert JD, Hong J, Yang G, et al. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. American Journal of Clinical Nutrition. 2005;81(Suppl):284S-291S.

Lee EH, Cho SY, Kim SJ, et al. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B induced apoptosis by maintaining constant levels of Bcl-2. Journal of Investigative Dermatology. 2003;121:607–613.

Li D, Yee JA, McGuire MH, Yan F. Soybean isoflavones reduce experimental metastasis in mice. Journal of Nutrition. 1999;29:1075–1078.

Manach C, Scalbert A, Morand D, et al. Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition. 2004;79:727–747.

Messina M, Barnes S. The role of soy products in reducing risk of cancer. Journal of the National Cancer Institute. 1991;83:541–546.

Monon LG, Kuttan R, Nail MG. Effect of isoflavone genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutrition and Cancer. 1998;30:74–77.

Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [VAL 12] Ha-ras-transformed NIH 3T3 cells. Biochemical and Biophysical Research Communications. 1988;157:183–189.

Pinnell SR. Cutaneous photodamage, oxidative stress and topical antioxidant protection. Journal of the American Academy of Dermatology. 2003;48:1–19.

Pratt DE, Di Pietro C, Porter WL, Giffee JW. Phenolic antioxidants of soy protein hydrolyzates. Journal of Food Science. 1981;47:24–25.

Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. Journal of Nutrition. 2000;130:2073S-2085S.

Tham DM. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. Journal of Clinical Endocrinology and Metabolism. 1998;83:2223–2235.

Wang Y, Yaping E, Zhang X, et al. Inhibition of ultraviolet B induced c-fos and c-jun expression by genistein through a protein tyrosine kinase-dependent pathway. Carcinogenesis. 1998;19:649–654.

Wei H, Bowen R, Zhang X, Lebwohl M. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis. Carcinogenesis. 1998;19:1509–1514.

Wei H, Cai Q, Rhan R. Inhibition of Fenton reaction and UV light-induced oxidative DNA damage by soybean isoflavone genistein. Carcinogenesis. 1996;17:73–77.

Yamaguchi M, Goa YH. Genistein inhibits bone loss. Biochemical Pharmacology. 1998;55:71-76.

Yao-Ping L, You-Rong L, Jian-Guo X, et al. Topical applications of caffeine or (–)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proceedings of the National Academy of Sciences USA. 2002;99:12455–12460.

Zwiller J, Sassone-Corsi P, Kakazu K, Boyton AL. Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor. Oncogene. 1991;6:219–221.